Clinical trial
Longitudinal Antimalarial Combinations in Uganda
NCT00123552 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00123552 |
|---|---|
| Title | Longitudinal Antimalarial Combinations in Uganda |
| Official title | Longitudinal Comparison of Combination Antimalarial Therapies in Ugandan Children: Evaluation of Safety, Tolerability, and Efficacy |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Amodiaquine+Artesunate, Amodiaquine+Sulfadoxine/Pyrimethamine, Artemether+Lumefantrine |
| Enrollment | 601 |
| Start date | Nov 1, 2004 |
| Primary completion | Jun 1, 2006 |
| Completion | Dec 1, 2008 |
| First posted | Jul 25, 2005 |
| Last update posted | Jun 9, 2020 |
| Countries | Uganda |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: